La chaîne d'options affiche les données clés des options sur actions de Plexus à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Plexus..

Plexus (NASDAQ:PLXS) Stock, Chaîne d'Options

PLEXUS CORP

Plexus

Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.

WIIM

PLXS

Plexus shares are trading higher after Sidoti & Co. upgraded the stock from Neutral to Buy and raised its price target from $135 to $150.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Deutsche Bank raised Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) price target from $97 to $105. Deutsche Bank analyst Brian Bedell maintained a Buy rating. Nasdaq shares closed at $93.50 on Thursday. See how other <a href="https://www.benzinga.com/quote/NDAQ/analyst-ratings">analysts view this stock</a>.</li>
<li>Keybanc increased the price target for United Rentals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) from $865 to $960. Keybanc analyst Ken Newman maintained an Overweight rating. United Rentals shares closed at $875.25 on Thursday. <a href="https://www.benzinga.com/quote/URI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan slashed Teck Resources Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TECK#NYSE">TECK</a>) price target from $46 to $41. JP Morgan analyst Bill Peterson downgraded the stock from Overweight to Neutral. Teck Resources shares closed at $35.12 on Thursday. <a href="https://www.benzinga.com/quote/TECK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies boosted the price target for Union Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) from $250 to $285. Jefferies analyst Stephanie Moore upgraded the stock from Hold to Buy. Union Pacific shares closed at $220.52 on Thursday. <a href="https://www.benzinga.com/quote/UN[/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Sidoti &amp; Co. increased the price target for Plexus Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) from $135 to $150. Sidoti &amp; Co. analyst Anja Soderstrom upgraded the stock from Neutral to Buy. Plexus shares closed at $118.29 on Thursday. <a href="https://www.benzinga.com/quote/PLXS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird raised Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) price target from $55 to $60. Baird analyst Daniel Moore maintained an Outperform rating. Knight-Swift Transportation shares settled at $45.55 on Thursday. <a href="https://www.benzinga.com/quote/KNX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt increased Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) price target from $625 to $650. Rosenblatt analyst Blair Abernethy maintained a Buy rating. Synopsys shares closed at $609.68 on Thursday. <a href="https://www.benzinga.com/quote/SNPS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel cut Henry Schein, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) price target from $80 to $75. Stifel analyst Jonathan Block downgraded the stock from Buy to Hold. Henry Schein shares closed at $72.62 on Thursday.  <a href="https://www.benzinga.com/quote/HSIC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt raised the price target for IMAX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMAX#NYSE">IMAX</a>) from $35 to $37. Rosenblatt analyst Steve Frankel maintained a Buy rating. IMAX shares settled at $28.29 on Thursday. <a href="https://www.benzinga.com/quote/IMAX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley increased Labcorp Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>) price target from $283 to $306. Morgan Stanley analyst Ricky Goldwasser maintained an Overweight rating. Labcorp shares closed at $267.69 on Thursday. <a href="https://www.benzinga.com/quote/lh/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying NDAQ stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="582" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25090118/image-401-1024x582.png" alt="" class="wp-image-1000765" style="width:593px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25090118/image-401-1024x582.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25090118/image-401-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25090118/image-401-768x436.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25090118/image-401.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46599936/top-2-tech-stocks-you-may-want-to-dump-this-quarter">Top 2 Tech Stocks You May Want To Dump This Quarter</a></li>
</ul>
Photo via Shutterstock

News

Price Target

Markets

Analyst Ratings

Trading Ideas

HSIC

IMAX

Laboratory Corporation Of America Holdings

NDAQ

SNPS

TECK

Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday

Ratings for Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Plexus, revealing an average target of $157.0, a high estimate of $160.00, and a low estimate of $150.00. This upward trend is evident, with the current average reflecting a 1.78% increase from the previous average price target of $154.25.
<img src="https://www.benzinga.com/files/images/story/2025/1753448460_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Plexus. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anja Soderstrom</td>
<td>Sidoti &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$158.00</td>
<td>$162.00</td>
</tr>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Plexus. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Plexus compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Plexus's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Plexus's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/PLXS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Plexus analyst ratings.</a>
<h2>Discovering Plexus: A Closer Look</h2>
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.
<h3>Financial Milestones: Plexus's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Positive Revenue Trend: Examining Plexus's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 3.89% as of 30 June, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Plexus's net margin is impressive, surpassing industry averages. With a net margin of 4.43%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Plexus's ROE stands out, surpassing industry averages. With an impressive ROE of 3.26%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Plexus's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.46% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Plexus's debt-to-equity ratio is below the industry average at 0.12, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Plexus: Insights From 4 Analyst Reviews

Sidoti &amp; Co. analyst Anja Soderstrom upgrades Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) from Neutral to Buy and raises the price target from $135 to $150.

Upgrades

Sidoti & Co. Upgrades Plexus to Buy, Raises Price Target to $150

Plexus shares are trading lower after the company reported mixed Q3 financial results and issued Q4 sales guidance below estimates. Also, the company issued Q4 GAAP EPS guidance below estimates.

Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) is looking for Q4 GAAP EPS of $1.57-$1.72 vs $1.82 analyst estimate..

Guidance

Plexus Sees Q4 GAAP EPS $1.57-$1.72 vs $1.82 Est

Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) is looking for Q4 Adj EPS of $1.82-$1.97 vs $1.87 analyst estimate. sees sales of $1.025 billion-$1.065 billion vs $1.085 billion analyst estimate.

Plexus Sees Q4 Adj EPS $1.82-$1.97 vs $1.87 Est; Sees Sales $1.025B-$1.065B vs $1.085B Est

Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.72 by 10.66 percent. This is a 31.03 percent increase over earnings of $1.45 per share from the same period last year. The company reported quarterly sales of $1.018 billion which missed the analyst consensus estimate of $1.021 billion by 0.34 percent. This is a 5.93 percent increase over sales of $961.000 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Plexus Q3 Adj. EPS $1.90 Beats $1.72 Estimate, Sales $1.018B Miss $1.021B Estimate

AMTB

ASGN

BANC

BPOP

BRKL

CADE

CBAN

CHDN

COOP

CSBR

CVBF

CVLG

EGBN

EPRT

EQNR

ESRT

First Trust Advantage Preferred Income Fund

FRME

FSBC

GLPG

GOOG

GOOGL

GSHD

HBNC

HCSG

ICLR

INBK

KALU

MTAL

NTRS

NTST

NVEC

ORLY

OTIS

OTLY

OXLC

PTEN

QCRH

RBBN

RELL

SEIC

SIGI

Earnings Scheduled For July 23, 2025

Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) is preparing to release its quarterly earnings on Wednesday, 2025-07-23. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Plexus to report an earnings per share (EPS) of $1.61.
The market awaits Plexus's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.12, leading to a 1.43% drop in the share price the following trading session.
Here's a look at Plexus's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.54</td>
<td>1.59</td>
<td>1.55</td>
<td>1.30</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.66</td>
<td>1.73</td>
<td>1.85</td>
<td>1.45</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>-10.0%</td>
<td>7.000000000000001%</td>
<td>12.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753207278_0.png" alt="eps graph" />
<h3>Plexus Share Price Analysis</h3>
Shares of Plexus were trading at $135.56 as of July 21. Over the last 52-week period, shares are up 15.42%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analysts' Perspectives on Plexus</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Plexus.
Analysts have given Plexus a total of 4 ratings, with the consensus rating being Buy. The average one-year price target is $160.5, indicating a potential 18.4% upside.
<h3>Comparing Ratings with Competitors</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of IPG Photonics, TTM Technologies and Sanmina, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for IPG Photonics, with an average 1-year price target of $70.0, suggesting a potential 48.36% downside.</li>
<li>Analysts currently favor an Buy trajectory for TTM Technologies, with an average 1-year price target of $41.12, suggesting a potential 69.67% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Sanmina, with an average 1-year price target of $110.0, suggesting a potential 18.86% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
In the peer analysis summary, key metrics for IPG Photonics, TTM Technologies and Sanmina are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Plexus</td>
<td>Buy</td>
<td>1.37%</td>
<td>$97.75M</td>
<td>2.93%</td>
</tr>
<tr>
<td>IPG Photonics</td>
<td>Buy</td>
<td>-9.61%</td>
<td>$89.81M</td>
<td>0.18%</td>
</tr>
<tr>
<td>TTM Technologies</td>
<td>Buy</td>
<td>13.78%</td>
<td>$130.97M</td>
<td>2.04%</td>
</tr>
<tr>
<td>Sanmina</td>
<td>Neutral</td>
<td>8.15%</td>
<td>$176.24M</td>
<td>2.87%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Plexus ranks highest in Revenue Growth among its peers. It also leads in Gross Profit. However, it falls behind in Consensus rating and Return on Equity. Overall, Plexus is positioned in the middle compared to its peers in the analysis.
<h3>Delving into Plexus's Background</h3>
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.
<h3>Plexus: Financial Performance Dissected</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Plexus's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.37% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Plexus's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 3.99%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Plexus's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.93% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.27%, the company showcases effective utilization of assets.
Debt Management: Plexus's debt-to-equity ratio is below the industry average. With a ratio of 0.18, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/PLXS/earnings">To track all earnings releases for Plexus visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What's Next: Plexus's Earnings Preview

Ratings for Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $160.5, a high estimate of $162.00, and a low estimate of $160.00. This current average represents a 3.02% decrease from the previous average price target of $165.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1749063668_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Plexus is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$160.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$162.00</td>
<td>$172.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Plexus. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Plexus compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Plexus's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Plexus's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/PLXS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Plexus analyst ratings.</a>
<h2>Discovering Plexus: A Closer Look</h2>
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.
<h3>Plexus: A Financial Overview</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Plexus displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 1.37%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Plexus's net margin is impressive, surpassing industry averages. With a net margin of 3.99%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Plexus's ROE stands out, surpassing industry averages. With an impressive ROE of 2.93%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Plexus's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.27%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.18.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Have This To Say About Plexus

Benchmark analyst David Williams reiterates Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) with a Buy and maintains $160 price target.

Reiteration

Benchmark Reiterates Buy on Plexus, Maintains $160 Price Target

Benchmark analyst David Williams maintains Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) with a Buy and lowers the price target from $170 to $160.

Benchmark Maintains Buy on Plexus, Lowers Price Target to $160

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>BMO Capital raised O&#8217;Reilly Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) price target from $1,450 to $1,500. BMO Capital analyst Tristan Thomas-Martin maintained an Outperform rating. O&#8217;Reilly Automotive shares closed at $1,352.17 on Thursday. See how other analysts <a href="https://www.benzinga.com/quote/ORLY/analyst-ratings">view this stock</a>.</li>
<li>Barclays cut the price target for Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) from $86 to $84. Barclays analyst Benjamin Budish maintained an Overweight rating. Nasdaq shares closed at $74.74 on Thursday. <a href="https://www.benzinga.com/quote/NDAQ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham cut Plexus Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) price target from $172 to $162. Needham analyst James Ricchiuti reiterated a Buy rating. Plexus shares closed at $125.35 on Thursday. See how other analysts <a href="https://www.benzinga.com/quote/PLXS/analyst-ratings">view this stock</a>.</li>
<li>Barclays increased the price target for AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) from $27 to $30. Barclays analyst Kannan Venkateshwar maintained an Overweight rating. AT&amp;T shares closed at $27.53 on Thursday. <a href="https://www.benzinga.com/quote/T/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity raised the price target for Rollins, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROL#NYSE">ROL</a>) from $49 to $50. Canaccord Genuity analyst Brian McNamara maintained a Hold rating. Rollins shares closed at $55.47 on Thursday. <a href="https://www.benzinga.com/quote/ROL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo increased Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) price target from $167 to $175. Wells Fargo analyst Ken Gawrelski maintained an Equal-Weight rating. Alphabet shares settled at $159.28 on Thursday. <a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS increased Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) price target from $130 to $170. UBS analyst Faham Baig upgraded Philip Morris from Sell to Neutral. Philip Morris shares closed at $170.07 on Thursday. <a href="https://www.benzinga.com/quote/PM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham cut Euronet Worldwide, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEFT#NASDAQ">EEFT</a>) price target from $130 to $120. Needham analyst Mayank Tandon maintained a Buy rating. Euronet Worldwide shares closed at $98.94 on Thursday.  <a href="https://www.benzinga.com/quote/EEFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan cut the price target for SS&amp;C Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) from $90 to $86. JP Morgan analyst Alexei Gogolev downgraded the stock from Overweight to Neutral. SS&amp;C Technologies shares settled at $77.43 on Wednesday. <a href="https://www.benzinga.com/quote/SSNC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt slashed Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) price target from $18 to $14. Rosenblatt analyst Kevin Cassidy maintained a Sell rating. Intel shares closed at $21.49 on Thursday. <a href="https://www.benzinga.com/quote/INTC/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying T stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="597" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177-1024x597.png" alt="" class="wp-image-888747" style="width:602px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177-1024x597.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177-768x448.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177.png 1093w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45001899/alphabet-intel-and-3-stocks-to-watch-heading-into-friday">Alphabet, Intel And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

EEFT

INTC

SSNC

AT&T To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Friday

Needham analyst James Ricchiuti reiterates Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) with a Buy and lowers the price target from $172 to $162.

Needham Reiterates Buy on Plexus, Lowers Price Target to $162

Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) is looking for Q3 GAAP EPS of $1.40-$1.55 vs $1.57 analyst estimate..

Plexus Sees Q3 GAAP EPS $1.40-$1.55 vs $1.57 Est

Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) is looking for Q3 Adj EPS of $1.65-$1.80 vs $1.70 analyst estimate. sees sales of $1.000 billion-$1.040 billion vs $1.03 billion analyst estimate.

Plexus Sees Q3 Adj EPS $1.65-$1.80 vs $1.70 Est; Sees Sales $1.000B-$1.040B vs $1.03B Est

Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) reported quarterly earnings of $1.66 per share which beat the analyst consensus estimate of $1.53 by 8.5 percent. This is a 76.6 percent increase over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $980.00 million which missed the analyst consensus estimate of $981.20 million by 0.12 percent. This is a 1.34 percent increase over sales of $967.00 million the same period last year.

Plexus Q2 Adj. EPS $1.66 Beats $1.53 Estimate, Sales $980.00M Miss $981.20M Estimate

Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) reported quarterly earnings of $1.41 per share which beat the analyst consensus estimate of $1.39 by 1.44 percent. The company reported quarterly sales of $980.000 million which missed the analyst consensus estimate of $981.200 million by 0.12 percent. This is a 1.34 percent increase over sales of $967.000 million the same period last year.

Plexus Q2 2025 GAAP EPS $1.41 Beats $1.39 Estimate, Sales $980.000M Miss $981.200M Estimate

Press Releases

Plexus Announces Fiscal Fourth Quarter and Fiscal Year 2024 Financial Results

Events

Sidoti Events, LLC's Virtual December Small-Cap Conference

Plexus Sets Fiscal First Quarter 2025 Earnings Release Date

Plexus Announces Fiscal First Quarter Financial Results

Plexus to Present at the Raymond James 46th Annual Institutional Investors Conference

Comments

Plexus

Plexus (PLXS) Options

Plexus (NASDAQ:PLXS) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL